FindTrial
Sign In

Effect of Haritakyadi tablet and Haritakyadi modak in children cough

A clinical comparative study of the efficacy of haritakyadi gutika with haritakyadi modak in the management of kaphaja kasa in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106847
Enrollment
30
Registered
2026-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

DR SRIRAM PRAJAPATI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed children of Kaphaja Kasa Children between the age of 5 years to 15 years of either sex

Exclusion criteria

Exclusion criteria: Children diagnosed with Pneumonia Croup syndrome Bronchial Asthma Tuberculosis or Malignancy Children with congenital anomalies or any other systemic or infectious disorders presenting with cough as a symptom

Design outcomes

Primary

MeasureTime frame
reducing excessive phlegm (Kapha Nisteevana), cough frequency (Kasavega), and chest heavinessTimepoint: 12 WEEKS—

Secondary

MeasureTime frame
Digestive & General Health ImprovementTimepoint: 12 WEEKS—

Countries

India

Contacts

Public ContactDR SRIRAM PRAJAPATI

shri babu singh jay singh ayurvedic medical college farrukhabad

mithilesh007.pathak@gmail.com7651982287

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026